About Constellation Pharmaceuticals

In July 2021, MorphoSys acquired Constellation Pharmaceuticals. This transformational acquisition bolstered MorphoSys' position as a leader in hematology and oncology and marked the beginning of an important next chapter in the company's history.​

MorphoSys' mission is to give more life for people with cancer. As a global commercial-stage biopharmaceutical company, MorphoSys uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. MorphoSys is headquartered in Planegg, Germany, and has its U.S. operations anchored in Boston, Massachusetts.

Facts about Constellation Pharmaceuticals
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Constellation Pharmaceuticals

Here you will find Constellation Pharmaceuticals